Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial
bemcentinib治疗对去甲基化药物治疗无效的晚期骨髓增生异常肿瘤或急性髓系白血病患者的疗效和安全性——EMSCO II期BERGAMO试验
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-023-02029-1
Kubasch, A S; Peterlin, P; Cluzeau, T; Götze, K S; Sockel, K; Teipel, R; Jentzsch, M; Attalah, H; Sebert, M; Chermat, F; Gloaguen, S; Puttrich, M; Cross, M; Schneider, M; Kayser, S; Schipp, D; Giagounidis, A; Tirado-Gonzalez, I; Descot, A; van de Loosdrecht, A; Weigert, A; Metzeler, K H; Fenaux, P; Medyouf, H; Platzbecker, U; Ades, L
